公司概覽
業務類別 Medical Devices
業務概覽 One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinalfixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
公司地址 Parkmore Business Park West, Building Two, Galway, IRL, 1
電話號碼 +353 14381700
傳真號碼 --
公司網頁 https://www.medtronic.com
員工數量 95000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Matthew R. Walter Senior Vice President and Chief Human Resources Officer -- 20/06/2025
Mr. Ivan K. Fong Executive Vice President, General Counsel and Corporate Secretary -- 20/06/2025
Mr. Michael Marinaro Executive Vice President and President, Medical Surgical Portfolio and Americas -- 20/06/2025
Ms. Denise L. Blomquist Vice President, Global Controller and Chief Accounting Officer -- 20/06/2025
Mr. Brett A. Wall Executive Vice President and President, Neuroscience Portfolio 美元 774.52K 20/06/2025
Mr. Skip Harry Kiil Executive Vice President and President, Cardiovascular Portfolio -- 21/05/2025
Mr. Geoffrey S. Martha Chief Executive Officer and Chairman of the Board 美元 1.35M 25/08/2025
Mr. Thierry Pieton Chief Financial Officer and Executive Vice President 美元 884.65K 20/06/2025
Ms. Que Thanh Dallara Chief Executive Officer, New Diabetes -- 21/05/2025
Mr. Michael Carter Senior Vice President and President, Cranial and spinal-Technologies business -- 21/05/2025
 
董事會成員
董事會 職務 更新日期
Dr. Joon Lee Independent Director 23/06/2025
Mr. Craig Arnold Lead Independent Director 25/08/2025
Mr. Kendall J. Powell Independent Director 25/08/2025
Ms. Lidia L. Fonseca Independent Director 25/08/2025
Mr. Randall J. Hogan, III Independent Director 25/08/2025
Mr. William R. Jellison Independent Director 19/08/2025
Mr. Scott C. Donnelly Independent Director 25/08/2025
Mr. John P. Groetelaars Independent Director 19/08/2025
Mr. Kevin E. Lofton Independent Director 25/08/2025
Mr. Geoffrey S. Martha Chief Executive Officer and Chairman of the Board 25/08/2025
Dr. Elizabeth G. Nabel, M.D. Independent Director 25/08/2025
Mr. Gregory P. Lewis Independent Director 25/08/2025
 
所屬ETF (更新日期: 07/03/2026 03:26)
代號 名稱 佔比% 持有日期
PQUSPictet AI Enhanced US Equity ETF0.000001%27/02/2026
AIEQAmplify AI Powered Equity ETF<0.000001%02/09/2025
AOMiShares Core 40/60 Moderate Allc ETF<0.000001%27/02/2026
BALIiShares U.S. Large Cap Prm Inc Act ETF<0.000001%28/02/2026
BALQiShares Nasdaq Premium Income Active ETF<0.000001%12/01/2026
BDVLiShares Disciplined Vol Eq Act ETF<0.000001%13/02/2026
BOBPCORE16 Best of Breed Premier Index ETF<0.000001%29/12/2025
CVRDMadison Covered Call ETF<0.000001%22/09/2025
DIVEDana Concentrated Dividend ETF<0.000001%30/09/2025
DIVGInvesco S&P 500 Hi Div Grwrs ETF<0.000001%21/10/2025
ESGGFlexShares STOXX Glbl ESG Select ETF<0.000001%22/09/2025
EVUSiShares ESG Aware MSCI USA Value ETF<0.000001%28/02/2026
FBUFFidelity Dynamic Buffered Equity ETF<0.000001%06/11/2025
FELCFidelity Enhanced Large Cap Core ETF<0.000001%20/02/2026
FHEQFidelity Hedged Equity ETF<0.000001%30/12/2025
FLSPFranklin Systematic Style Premia ETF<0.000001%17/02/2026
FTLSFirst Trust Long/Short Equity ETF<0.000001%02/12/2025
FYEEFidelity Yield Enhanced Equity ETF<0.000001%13/11/2025
GCOWPacer Global Cash Cows Dividend ETF<0.000001%22/12/2025
GLVClough Global Dividend and Income<0.000001%31/10/2025
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15   16    17    18    19  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.